Medicale (MCLE) EBIAT (2020 - 2025)
Medicale (MCLE) has disclosed EBIAT for 6 consecutive years, with -$10670.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT rose 36.79% year-over-year to -$10670.0, compared with a TTM value of -$41153.0 through Sep 2025, up 29.31%, and an annual FY2025 reading of -$41153.0, up 29.31% over the prior year.
- EBIAT was -$10670.0 for Q3 2025 at Medicale, down from -$5528.0 in the prior quarter.
- Across five years, EBIAT topped out at -$5528.0 in Q2 2025 and bottomed at -$19307.0 in Q4 2023.
- Average EBIAT over 5 years is -$10611.4, with a median of -$8537.0 recorded in 2023.
- The sharpest move saw EBIAT skyrocketed 55.82% in 2022, then tumbled 133.77% in 2023.
- Year by year, EBIAT stood at -$18696.0 in 2021, then surged by 55.82% to -$8259.0 in 2022, then crashed by 133.77% to -$19307.0 in 2023, then increased by 13.61% to -$16680.0 in 2024, then soared by 36.03% to -$10670.0 in 2025.
- Business Quant data shows EBIAT for MCLE at -$10670.0 in Q3 2025, -$5528.0 in Q2 2025, and -$8275.0 in Q1 2025.